Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published Date:

Abstract

PURPOSE: Contemporary adherence of the indication to European Association of Urology (EAU) guideline recommendation for pelvic lymph node dissection (PLND) at either open (ORP) or robot-assisted radical prostatectomy (RARP) at a high-volume center is unknown. To assess guideline recommended and observed PLND rates in a high-volume center cohort.

Authors

  • J Schiffmann
    Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada. Electronic address: schiffmann@martini-klinik.de.
  • A Haese
    Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sami-Ramzi Leyh-Bannurah
    Sami-Ramzi Leyh-Bannurah, Dirk Pehrke, Hartwig Huland, Markus Graefen, and Lars Budäus, Prostate Cancer Center Hamburg-Eppendorf; Sami-Ramzi Leyh-Bannurah, Margit Fisch, and Guido Sauter, University Medical Center Hamburg-Eppendorf, Hamburg; Ulrich Wolffgang, University of Muenster, Muenster, Germany; and Zhe Tian and Pierre I. Karakiewicz, University of Montreal Health Center, Montreal, Canada.
  • G Salomon
    Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
  • T Steuber
    Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
  • T Schlomm
    Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
  • K Boehm
  • B Beyer
    Martini-Klinik, Prostatakrebszentrum, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Deutschland, beyer@martini-klinik.de.
  • A Larcher
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, Vita-Salute San Raffaele University, Milan, Italy.
  • U Michl
    Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
  • H Heinzer
    Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
  • H Huland
    Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
  • M Graefen
    Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany.
  • P I Karakiewicz
    Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada; Department of Urology, University of Montreal Health Center, Montreal, Canada.